Patents by Inventor Emmaus Medical, Inc.

Emmaus Medical, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for the treatment of diverticulosis
    Publication number: 20130178531
    Abstract: The present invention is directed to methods and compositions for the treatment of diverticulosis. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diverticulosis. In a method aspect, the present invention provides a method of treating diverticulosis. The method includes ingestion of 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diverticulosis.
    Type: Application
    Filed: December 14, 2012
    Publication date: July 11, 2013
    Applicant: Emmaus Medical, Inc.
    Inventor: Emmaus Medical, Inc.
  • Methods and compositions for the treatment of diabetes and related symtoms
    Publication number: 20130143968
    Abstract: The present invention is directed to methods and compositions for the treatment of diabetes and related symptoms. It is more specifically directed to compositions including L-glutamine, its salts, or its derivatives, and uses of such compositions in the treatment of diabetes and related symptoms. In a method aspect, the present invention provides a method of treating diabetes. The method involves ingesting 0.05 g/kg body weight to 10.0 g/kg body weight of L-glutamine, an L-glutamine salt or an L-glutamine derivative per day by a person who has diabetes.
    Type: Application
    Filed: November 17, 2012
    Publication date: June 6, 2013
    Applicant: Emmaus Medical, Inc.
    Inventor: Emmaus Medical, Inc.